Secondary thrombocythemia in children
Clinically, in certain physiological states (such as after exercise) and different types of acute and chronic diseases, the platelet count may rise to more than 400×109/L, which is called secondary (reactive) thrombocythemia. The cause can be determined from the medical history and clinical manifestations. Thrombocytosis refers to the platelet count exceeding the upper limit of the normal value. The platelet count often exceeds 1000×109/L (1 million/mm3) and can reach 14000×109/L (14 million/mm3). The platelet size is abnormal and giant, which is extremely rare in children. Mucosal bleeding is the main symptom, such as hematuria, gastrointestinal bleeding, and epistaxis.
-
Site of disease:
Blood vessels skin -
Infectious :
Not contagious -
Frequent population:
Children -
Related symptoms:
Muscle bleeding Gastrointestinal bleeding With skin and mucosal bleeding Thrombocytosis Macules -
Concurrent disease:
Related Drugs
Dipyridamole
Indication: This product was once a commonly used drug for the treatment of coronary heart disease, but is now rarely used to prevent myocardial ischemia. Its antiplatelet aggregation effect can be used in heart surgery or valve replacement surgery to reduce the formation of thromboembolism.
Manufacturer:
Yabao Pharmaceutical Group Co., Ltd.
aspirin
Indication: 1. Analgesic and antipyretic; 2. Anti-inflammatory and anti-rheumatic; 3. Arthritis; 4. Anti-thrombotic; 5. Mucocutaneous lymph node syndrome (Kawasaki disease); 6. Prevention of gastrointestinal tumors; 7. Inhibition of platelet aggregation.
Manufacturer:
Wuyi Cihang Pharmaceutical Co., Ltd.
Related Ingredients